Form 4: Heron Therapeutics CEO Craig Collard Acquires Stock Options and Restricted Stock Units
SEC Form 4
CEO Craig Collard reports acquisition of stock options and restricted stock units in Heron Therapeutics, Inc.
Summary
- Craig Collard, CEO of Heron Therapeutics, Inc., filed a Form 4 on February 4, 2025, reporting changes in beneficial ownership.
- On January 31, 2025, Collard acquired 1,113,240 employee stock options with an exercise price of $1.70, vesting monthly over four years and expiring on January 31, 2035.
- He also acquired 556,620 restricted stock units (RSUs) that vest quarterly over four years.
- Following these transactions, Collard directly owns 1,113,240 stock options and 556,620 RSUs.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard regulatory filing detailing executive compensation. The vesting schedule suggests a long-term commitment from the CEO, which is mildly positive.
Positives
- The acquisition of stock options and RSUs by the CEO could be seen as a positive sign, indicating confidence in the company's future performance.
Future Outlook
The vesting schedules for the stock options and RSUs suggest a long-term commitment from the CEO.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Comparison to Industry Standards
- Stock option and RSU grants are common forms of executive compensation in the biotechnology industry, aligning management's interests with those of shareholders.
- Vesting schedules are typical for these types of grants, incentivizing long-term performance and retention.
Stakeholder Impact
- The grant of stock options and RSUs could potentially align the CEO's interests with those of shareholders, incentivizing value creation.
Key Dates
| Date | Description |
|---|---|
| 01/31/2025 | Date of transaction: Acquisition of stock options and restricted stock units. |
| 01/31/2025 | Stock options vest in 48 equal monthly installments beginning one month after this date. |
| 01/31/2025 | Restricted stock units vest in 16 equal quarterly installments beginning one quarter after this date. |
| 01/31/2035 | Expiration date of the stock options. |
| 02/04/2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.